Causal associations of BAFF-R on IgD+ CD24- B cell immune cell trait with hepatocellular carcinoma and the mediating role of phenylacetylglutamate levels: a Mendelian randomization study

Author:

Zhu Xuan1,Qiu Zongchao2,Yang Maochun1,Kong Lingxi1,Li Limin1,Huang Yingting1,Xie Li1

Affiliation:

1. Department of Medical Laboratory, Second Affiliated Hospital of Guangxi Medical University

2. Fujian Yuanshizhuling Community Health Service center

Abstract

Abstract

Background We conducted a bi-directional two-sample Mendelian randomization (MR) analysis to investigate the causal associations between immune cell traits and hepatocellular carcinoma (HCC) and identify the mediating factor of metabolites. Methods The exposure factors were immune cell traits, the mediators were metabolites, and the outcome variable was HCC. Inverse-variance weighted method (IVW) was the main method. Weighted median, MR-Egger regression, weighted mode, simple mode, and MR pleiotropy residual sum and outlier (MRPRESSO) methods were used as complementary methods. Subsequently, the potential mediating effect was investigated by conducting a two-step Mediation analysis. Results We found 7 traits with positive correlations and 19 traits with negative correlations between immune cell traits and HCC. There were no causal correlations between HCC and immune cell traits in the reverse MR analysis. In the mediation analysis, we found a positive causal association between B cell-activating factor receptors (BAFF-R) on IgD+ CD24- B cell and HCC [IVW: odd ratio (OR), 0.845; 95% CI, 0.759-0.942; p = 0.002]. Phenylacetylglutamate (PAG) levels mediated 7.353% of the causal pathway from BAFF-R on IgD+ CD24- B cell and HCC. Conclusion BAFF-R on IgD+ CD24- B cell lowers risk of HCC, with PAG levels playing a mediating role.

Publisher

Research Square Platform LLC

Reference38 articles.

1. Epidemiology and Management of Hepatocellular Carcinoma;Kulik LE-SH;Gastroenterology,2019

2. Sung HFJ, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021;71(3):209 – 49.

3. A global view of hepatocellular carcinoma: trends, risk, prevention and management;Yang JD;Nat Reviews Gastroenterol Hepatol,2019

4. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study;Park JW;Liver Int,2015

5. Immunotherapies for hepatocellular carcinoma;Llovet JM;Nat Reviews Clin Oncol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3